KBC Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62K | Hold |
12,307
| – | – | ﹤0.01% | 1486 |
|
|
2025
Q1 | $65K | Hold |
12,307
| – | – | ﹤0.01% | 1711 |
|
|
2024
Q4 | $83K | Buy |
12,307
+4,705
| +62% | +$31.7K | ﹤0.01% | 1665 |
|
|
2024
Q3 | $50K | Buy |
7,602
+3,377
| +80% | +$22.2K | ﹤0.01% | 1710 |
|
|
2024
Q2 | $32K | Hold |
4,225
| – | – | ﹤0.01% | 1807 |
|
|
2024
Q1 | $42K | Hold |
4,225
| – | – | ﹤0.01% | 1644 |
|
|
2023
Q4 | $42K | Hold |
4,225
| – | – | ﹤0.01% | 1651 |
|
|
2023
Q3 | $32K | Buy |
+4,225
| New | +$32K | ﹤0.01% | 1759 |
|